Dr. Erinjeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 2007 - 2008
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2007 - 2008
- Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 2003 - 2007
- Virginia Mason Franciscan HealthInternship, Internal Medicine, 2002 - 2003
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2007 - 2026
- NJ State Medical License 2017 - 2025
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Vascular & Interventional Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 113 citationsImage-guided Thermal Ablation of Tumors Increases the Plasma Level of Interleukin-6 and Interleukin-10Joseph P. Erinjeri, C.T. Thomas, Alaiksandra Samoilia, Martin Fleisher, Mithat Gonen
Journal of Vascular and Interventional Radiology. 2013-08-01 - 133 citationsDetection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CTGary A. Ulaner, David M. Hyman, Dara S. Ross, Adriana D. Corben, Sarat Chandarlapaty
Journal of Nuclear Medicine. 2016-10-01 - 35 citationsEvaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastasesSho Fujisawa, Yevgeniy Romin, Afsar Barlas, Lydia M. Petrovic, Mesruh Turkekul
Cytotechnology. 2014-03-01
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
- Schedule at A GlanceJune 8th, 2015
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: